Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00521651 · ClinicalTrials.gov registry record
PRelationship Between Physical Activity and Cancer Ris
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 620
- Enrollment target
NCT00521651: Completed study, sponsored by National Cancer Institute (NCI).
NCT00521651 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 620 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00521651 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 620 participants
- Enrollment target
Study Summary
This protocol is a sub-study of the ongoing "Protect Health and Reduce Cancer Risk" study conducted in Shanghai, China, and sponsored by the Shanghai Cancer Institute, Vanderbilt University, and the National Cancer Institute. The parent study is designed to examine the relationship of diet, lifestyle, occupational, and environmental risk factors, as well as genetic variation, to cancer incidence in a large cohort of men in women between 40 and 70 years of age. The current sub-study will assess the validity and reliability of a new physical activity questionnaire for use in the parent study and to evaluate whether different types of activity and the frequency, intensity, and duration of activity are associated with markers that have been linked to cancer risk, such as C-reactive protein, interleukin 6 and soluble tumor necrosis factor alpha. Participants in the current 12-month study are selected from among men and women participating in the "Protect Health and Reduce Cancer Risk" study. Participants keep a diary of their physical activity and complete two 30-minute interviews about their physical activity, one at the beginning and one at the end of the study period. Every 3 months for 7 consecutive days, they wear a pager-sized activity monitor on their waist that records their physical activity patterns during that period of time. They provide blood and urine samples four times during the study and, at the end of the study, undergo a health examination that includes an electrocardiogram, body composition measurement, and physical fitness test. The fitness test is a step-test consisting of 3-minute stages in which the subject successively increases the stepping speed until reaching 85 percent of his or her predicted maximal heart rate. Blood and urine samples are analyzed for levels of nutrients and certain proteins, and are stored for future studies related to nutrition and physical activity and possibly for genetic studies related to health, nutrition, exercise,
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 620 participants |
| Start Date | 2005-08-01 |
| Est. Completion | 2009-04-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00521651
The ClinicalTrials.gov registry entry for NCT00521651 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 620 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00521651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00521651 about?
NCT00521651 is a clinical study titled "PRelationship Between Physical Activity and Cancer Ris". This protocol is a sub-study of the ongoing "Protect Health and Reduce Cancer Risk" study conducted in Shanghai, China, and sponsored by the Shanghai Cancer Institute, Vanderbilt University, and the National Cancer Institute. The parent study is designed to examine the relationship of diet, lifestyl...
What is the current status of trial NCT00521651?
This trial is currently completed. The enrollment target is 620 participants. The study started on 2005-08-01. Estimated completion is 2009-04-23.
Who is sponsoring clinical trial NCT00521651?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.